Publication | Closed Access

Safety and Efficacy of Self-Administered Subcutaneous Immunoglobulin in Patients with Primary Immunodeficiency Diseases

Primary ImmunodeficiencyAutoimmune DiseaseTreatment And PreventionImmunodeficienciesImmunologyPrimary Immunodeficiency DiseasesAutoimmunityImmunologic DiseaseSelf-administered Subcutaneous ImmunoglobulinChronic Viral InfectionHivImmunotherapyMedicineAids Pathogenesis